| Myeloid-derived suppressor cells regulate growth of multiple myeloma by inhibiting T cells in bone marrow IR Ramachandran, A Martner, A Pisklakova, T Condamine, T Chase, ... The Journal of immunology 190 (7), 3815-3823, 2013 | 249 | 2013 |
| Neurotrophin signaling via TrkB and TrkC receptors promotes the growth of brain tumor-initiating cells S Lawn, N Krishna, A Pisklakova, X Qu, DA Fenstermacher, M Fournier, ... Journal of Biological Chemistry 290 (6), 3814-3824, 2015 | 155 | 2015 |
| Canonical Wnt pathway inhibitor ICG-001 induces cytotoxicity of multiple myeloma cells in Wnt-independent manner ER Grigson, M Ozerova, A Pisklakova, H Liu, DM Sullivan, Y Nefedova PloS one 10 (1), e0117693, 2015 | 53 | 2015 |
| M011L-deficient oncolytic myxoma virus induces apoptosis in brain tumor-initiating cells and enhances survival in a novel immunocompetent mouse model of glioblastoma A Pisklakova, B McKenzie, F Zemp, X Lun, RS Kenchappa, AB Etame, ... Neuro-oncology 18 (8), 1088-1098, 2016 | 52 | 2016 |
| Gamma-secretase inhibitor enhances the cytotoxic effect of bortezomib in multiple myeloma F Chen, A Pisklakova, M Li, R Baz, DM Sullivan, Y Nefedova Cellular oncology 34, 545-551, 2011 | 42 | 2011 |
| In vitro screen of a small molecule inhibitor drug library identifies multiple compounds that synergize with oncolytic myxoma virus against human brain tumor-initiating cells BA McKenzie, FJ Zemp, A Pisklakova, A Narendran, G McFadden, X Lun, ... Neuro-oncology 17 (8), 1086-1094, 2015 | 33 | 2015 |
| Anti-myeloma effect of pharmacological inhibition of Notch/gamma-secretase with RO4929097 is mediated by modulation of tumor microenvironment A Pisklakova, E Grigson, M Ozerova, F Chen, DM Sullivan, Y Nefedova Cancer Biology & Therapy 17 (5), 477-485, 2016 | 11 | 2016 |
| Cauda Equina syndrome as the initial presentation of concurrent plasmacytoma and multiple myeloma A Pisklakova, C Almanzar, JP Sambataro, O Ansari, F Manji Cureus 13 (1), 2021 | 2 | 2021 |
| ODP220 Latent Autoimmune Diabetes of Adults and PCOS-an Unusual Combination A Pisklakova, M Nagrani, S Mohanachandran, J Abraham Journal of the Endocrine Society 6 (Suppl 1), A324, 2022 | 1 | 2022 |
| Silent Thrombotic Thrombocytopenic Purpura: PLASMIC, Lessons Learned, and Current Management Overview A Pisklakova, J Barbir, JP Sambataro, C Almanzar, F Manji Cureus 13 (3), 2021 | 1 | 2021 |
| M011L-DEFICIENT ONCOLYTIC MYXOMA VIRUS INDUCES APOPTOSIS IN BRAIN TUMOR INITIATING CELLS AND ENHANCES SURVIVAL IN A NOVEL IMMUNOCOMPETENT MOUSE MODEL OF GLIOBLASTOMA P Forsyth, R Kenchappa, B McKenzie, A Pisklakova, ND Tran, ... NEURO-ONCOLOGY 18, 68-68, 2016 | 1 | 2016 |
| MALT LYMPHOMA LEADING TO INTERSTITIAL LUNG DISEASE CA Zorrilla, J Sambataro, A Pisklakova, K Patel, C Acevedo-Cajigas, ... Chest 160 (4), A1203, 2021 | | 2021 |
| The Unlucky Truck Driver CA Zorrilla, K Patel, O Ansari, A Pisklakova, S Tran, J Perez TP141. TP141 THORACIC ONCOLOGY: RARE THORACIC MALIGNANCIES, A4900-A4900, 2021 | | 2021 |
| 777: An Atypical Presentation of PRES and the Case for DWI for Prognostication J Sambataro, T Persaud, A Pisklakova, M Nagrani, M Posada, H Lief, ... Critical Care Medicine 49 (1), 385, 2021 | | 2021 |
| M011L-deficient oncolytic myxoma virus to induce apoptosis in brain tumor initiating cells and to enhance survival in a novel immunocompetent mouse model of glioblastoma. R Kenchappa, B McKenzie, A Pisklakova, G McFadden, PAJ Forsyth Journal of Clinical Oncology 34 (15_suppl), e13521-e13521, 2016 | | 2016 |
| ATPS-65AN ONCOLYTIC MYXOMA VIRUS CONSTRUCT (M011L KNOCK-OUT) INDUCES APOPTOSIS AND IS A POTENT PRO-APOPTOTIC THERAPY IN BOTH HUMAN AND IMMUNOCOMPETENT MURINE GLIOBLASTOMA … A Pisklakova, B McKenzie, F Zemp, R Kenchappa, G McFadden, ... Neuro-oncology 17 (Suppl 5), v32, 2015 | | 2015 |
| An Oncolytic Myxoma Virus Construct (M011L Knock-out) Induces Apoptosis and is a Potent Pro-Apoptotic Therapy in both Human and Immunocompetent Murine Glioblastoma Cancer Stem … A Pisklakova Neurology 84 (14_supplement), P4. 247, 2015 | | 2015 |
| ET-46ONCOLYTIC VIRAL THERAPY FOR MALIGNANT GLIOMAS USING MYXOMA VIRUS DELETED FOR ANTI-APOPTOTIC M11L GENE A Pisklakova, B McKenzie, R Kenchappa, G McFadden, P Forsyth Neuro-Oncology 16 (Suppl 5), v89, 2014 | | 2014 |
| ONCOLYTIC VIRAL THERAPY FOR MALIGNANT GLIOMAS USING MYXOMA VIRUS DELETED FOR ANTI-APOPTOTIC M11L GENE B McKenzie, A Pisklakova, G McFadden, R Kenchappa, P Forsyth NEURO-ONCOLOGY 16, 144-144, 2014 | | 2014 |
| Oncolytic viral therapy for malignant gliomas using myxoma virus deleted for antiapoptotic M11L gene. PAJ Forsyth, B McKenzie, A Pisklakova, R Kenchappa, G McFadden Journal of Clinical Oncology 32 (15_suppl), 3105-3105, 2014 | | 2014 |
